Suspension of the licence of ZERIN® (Paracetamol) Tablets 500mg

The Health Sciences Authority wishes to alert healthcare professionals on the suspension of the licence of Zerin® tablets 500mg, due to product defects that have been reported since August 2011. Zerin® tablets contain paracetamol and are distributed in Singapore by Ziwell Medical (S) Pte Ltd. Some tablets from different batches were found to contain small foreign particles. Testing by HSA's laboratories has shown that the foreign particles are inert, non-toxic substances and assessed to pose minimal risk to consumers. Although the health risk to the individual consumer is low, HSA is suspending the licence of Zerin® tablets as a precautionary measure, to prevent the exposure of members of the public to a product that is not compliant to quality standards. Healthcare professionals are advised to stop prescribing the Zerin ® Tablets andadvise their patients to stop consuming the medicine.